Pharmaceutical Construction Emerges as a Bright Spot in North American Manufacturing
A bright spot in the North American economy continues to be construction in the advanced manufacturing sector, though the makeup of that sector has shifted noticeably over the past few years. After a surge of investment in electric vehicle production facilities, the momentum in early 2026 has turned toward pharmaceutical and biomanufacturing projects.
Major producers including AstraZeneca, Eli Lilly, and Johnson & Johnson are advancing significant capital programs across the U.S. and Canada. Engineering News‑Record recently highlighted Genentech’s expansion in North Carolina as an example of how biopharmaceutical owners are increasing project scope even as the industry grapples with labor shortages and the inherent complexity of facilities that rank among the most infrastructure‑intensive industrial builds.
Navigating the Unique Challenges of Pharmaceutical Construction
Pharmaceutical projects bring a distinct set of challenges compared to other industrial sectors. Sites often operate within limited footprints, are sometimes located near residential communities, and require tightly coordinated construction activity to maintain safety, cleanliness, and schedule integrity. These constraints elevate the importance of how contractors and owners manage indirect services, material flow, and onsite logistics, Efficient site planning isn’t just a matter of convenience — it directly affects productivity, congestion, and the ability to hit critical milestones on projects where precision is non-negotiable.
A Total-Site Approach to Keeping Projects Productive
For decades, AMECO has supported complex pharmaceutical builds across North America, applying a total-site approach to indirect construction services that helps project teams stay productive, even in constrained environments.
That approach centers on thoughtful pre-planning and coordinated delivery of the resources every jobsite relies on — from scaffolding and small tools to modular offices and power distribution. By streamlining how these services are provided, teams can avoid material pile-up, reduce unnecessary equipment onsite, and make better use of limited space. The result is a cleaner, safer, and more efficient jobsite that keeps construction moving.
Looking Ahead
With pharmaceutical investment gaining momentum, owners and contractors are increasingly seeking partners who can help them manage complexity and maintain productivity amid tight footprints and rising demand. A disciplined approach to indirect services can be a critical differentiator — not only for project execution, but for workforce efficiency and overall cost performance. Tolearn more about how a total-site strategy supports safe, efficient, high-performing projects, contact a Site Services expert at AMECO.